Related references
Note: Only part of the references are listed.Real-World Safety and Efficacy of Consolidation Durvalumab After Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis
Yu Wang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
David R. Spigel et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
Qing Zhou et al.
LANCET ONCOLOGY (2022)
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era
Chiara Catania et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
Concurrent Chemo-Proton Therapy Using Adaptive Planning for Unresectable Stage 3 Non-Small Cell Lung Cancer: A Phase 2 Study
Hiromitsu Iwata et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Stereotactic Body Radiation Therapy With a High Maximum Dose Improves Local Control, Cancer-Specific Death, and Overall Survival in Peripheral Early-Stage Non-Small Cell Lung Cancer
Yudai Tateishi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancer
Yosef Landman et al.
ONCOIMMUNOLOGY (2021)
Proton therapy for locally advanced non-small cell lung cancer
Olsi Gjyshi et al.
BRITISH JOURNAL OF RADIOLOGY (2020)
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
K. Park et al.
ANNALS OF ONCOLOGY (2020)
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer
Jeffrey D. Bradley et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Phase II prospective trial of primary lung tumor stereotactic body radiation therapy (SBRT) followed by concurrent mediastinal chemoradiation and adjuvant immunotherapy for locally-advanced non-small cell lung cancer (NSCLC): Planned toxicity analysis.
John H Heinzerling et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Radiotherapy for unresectable locally advanced non-small cell lung cancer: a narrative review of the current landscape and future prospects in the era of immunotherapy
Tiantian Guo et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer
Adnan Elhammali et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study
Dirk De Ruysscher et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Patterns of Disease Progression with Durvalumab in Stage III Non-small Cell Lung Cancer (PACIFIC)
D. Raben et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)
Judi van Diessen et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study
Melenda D. Jeter et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
Zhongxing Liao et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer Findings From the NRG Oncology RTOG 0618 Trial
Robert D. Timmerman et al.
JAMA ONCOLOGY (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer
Robert T. Dess et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance)
Steven E. Schild et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer A Phase 2 Clinical Trial
Feng-Ming Kong et al.
JAMA ONCOLOGY (2017)
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer Final Results of a Phase 2 Study
Joe Y. Chang et al.
JAMA ONCOLOGY (2017)
Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study
Jaroslaw T. Hepel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Acute esophagitis for patients with local-regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy
Yi Pan et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial
Benjamin Movsas et al.
JAMA ONCOLOGY (2016)
Computed Tomographye-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral None-Small Cell Lung Cancer: A Phase 1 Clinical Trial
Li Xiang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small-Cell Lung Cancer Beneficial? A Multi-Institutional Propensity Score Matched Analysis
George Rodrigues et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)
Gregory M. M. Videtic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04
Jin Seok Ahn et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley et al.
LANCET ONCOLOGY (2015)
30 Gy or 34 Gy? Comparing 2 Single-Fraction SBRT Dose Schedules for Stage I Medically Inoperable Non-Small Cell Lung Cancer
Gregory M. M. Videtic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
HIGHER BIOLOGICALLY EFFECTIVE DOSE OF RADIOTHERAPY IS ASSOCIATED WITH IMPROVED OUTCOMES FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CARCINOMA TREATED WITH CHEMORADIATION: AN ANALYSIS OF THE RADIATION THERAPY ONCOLOGY GROUP
Mitchell Machtay et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma A Radiation Therapy Oncology Group Analysis
Mitchell Machtay et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Computerized tomography-guided percutaneous high-dose-rate interstitial brachytherapy for malignant lung lesions
Daya Nand Sharma et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2011)
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
Walter J. Curran et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
Anne Auperin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Quality Improvement Guidelines for Percutaneous Needle Biopsy
Sanjay Gupta et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
CT-guided interstitial brachytherapy of primary and secondary lung malignancies -: Results of a prospective phase II trial
Nils Peters et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2008)
Stereotactic body radiation therapy - A comprehensive review
Brian K. Chang et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer
Robert Timmerman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
CT-guided interstitial single-fraction brachytherapy of lung tumors -: phase I results of a novel technique
J Ricke et al.
CHEST (2005)
Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial
D Cella et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
